A practical reference on peptide purity: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-19 and is reviewed periodically as new material appears.
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
| Property | Value | Notes |
|---|---|---|
| Identity confirmation | Reversed-phase HPLC retention time versus reference standard | Retention depends on column, gradient, and ion-pairing agent |
| Mass confirmation | Electrospray or MALDI mass spectrometry | Doubly protonated ion near m/z 377 is consistent with about 752 Da |
| Typical purity specification | 95 percent or higher by chromatographic peak area | Lower values suggest truncated or modified peptide species |
| Storage of lyophilized powder | -20 °C, desiccated, protected from light | Powder tolerates long storage better than solution |
| Storage of solution | 2-8 °C for short periods | Freeze-thaw cycling promotes aggregation and surface adsorption |
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
(1933), first African-American basketball player to be selected as All-American Alfred Skrobisch (1933), Olympic fencer Cliff Montgomery (1934), led the Columbia Lions football team to victory in the Rose Bowl John O'Brien (1938), basketball player for the Akron Wingfoots Ben Johnson (1938), sprinter who rivaled Jesse Owens Sid Luckman (1939), NFL Hall of Fame Chicago Bears quarterback Ken Germann (1943), football coach, athletic director of Columbia University, and former Southern Conference commissioner Paul Governali (1943), football player for the Boston Yanks and New York Giants Walt Budko (1948), basketball player for Baltimore Bullets and Philadelphia Warriors Bruce Gehrke (1948), football player for New York Giants Bill Swiacki (1948), player for New York Giants, member of the College Football Hall of Fame Lou Kusserow (1949), football player for Hamilton Tiger-Cats and New York Yanks John Azary (1951), basketball player, recipient of the Haggerty Award Jack Molinas (1953), NBA player for the Fort Wayne Pistons Jack Rohan (1953), head coach of the Columbia Lions men's basketball team 1961–1974, and 1990–1995 George Shaw (1953), Olympic triple jumper Richard Ballantine* (1967), cyclist and cycling advocate; son of Ian Ballantine '38 of Ballantine Books James Margolis (1958), Olympic fencer James Melcher (1961), Olympian fencer, president of Fencers Club and hedge fund manager Robert Contiguglia (1963), soccer player, former president of the United States Soccer Federation Peter Salzberg (1964), head coach of Vermont Catamounts men's basketball 1972–1981 Archie Roberts (1965), former football player for the Miami Dolphins and cardiac surgeon Jim McMillian (1968), NBA player for the Los Angeles Lakers, Buffalo Braves, New York Knicks and Portland Trail Blazers Dave Newmark (1968), NBA player for the Chicago Bulls; also played for Israeli team Hapoel Tel Aviv B.C. Marty Domres (1969), football player for San Diego Chargers and Baltimore Colts Heyward Dotson (1970), basketball player George Starke (1971), offensive lineman for the Washington Redskins Henry Bunis (1975), two-time All-American tennis player, runner-up in 1977 Chilean Open Rick Fagel (1975), professional tennis player Vitas Gerulaitis* (1975), champion tennis player Thomas Losonczy (1975), Olympic fencer, winner of the Congressional Gold Medal Alton Byrd (1979), basketball player Eric Fromm (1980), tennis player John Witkowski (1983), football player for Detroit Lions and Houston Oilers Gene Larkin (1984), member of the Minnesota Twins 1987 and 1991 World Series championship teams Amr Aly (1985), soccer player who won the Hermann Trophy as the top college player of the year 1984; member of the 1984 U.S. Olympic Soccer Team and indoor soccer team Los Angeles Lazers Stephen Trevor (1986), Olympic fencer Kyra Tirana Barry (1987), team leader for U.S. women's national wrestling team Caitlin Bilodeaux (1987), Olympic fencer Howard Endelman (1987), tennis player Phil Williamson (1987), tennis player for Antigua and Barbuda Bob Cottingham (1988), Olympic fencer Jon Normile (1989), Olympic fencer Frank Seminara (1989), Major League Baseball pitcher for the San Diego Padres and the New York Mets Tom Auth (1990), Olympic rower Christine Vardaros (1991), professional cyclist Ann Marsh (1994), Olympic fencer Ríkharður Daðason (1996), Icelandic soccer player Marcellus Wiley (1997), football player for the Buffalo Bills, San Diego Chargers and Dallas Cowboys Dan Kellner (1998), fencer Pellegrino Matarazzo (1999), head coach of VfB Stuttgart Matt Napoleon (1999), Olympic soccer goalkeeper Cristina Teuscher (2000), Olympic gold medalist swimmer Jedediah Dupree (2001), NCAA Champion fencer Veljko Urošević (2003), Serbian Olympic rower Fernando Perez (2004), outfielder for the Tampa Bay Rays Jeremiah Boswell (2005), professional basketball player for BC Sliven, KK Strumica, and KK Torus Delilah DiCrescenzo (2005), long-distance runner, inspiration and subject of the Grammy-nominated song Hey There Delilah Michael Quarshie (2005), Finnish American football player who played for the Oakland Raiders and Frankfurt Galaxy Lisa Nemec (2006), Croatian long-distance runner Miloš Tomić (2006), Serbian Olympic rower Erison Hurtault (2007), Dominican sprinter James Leighman Williams (2007), fencer who won silver in the 2008 Summer Olympics Emily Jacobson (2008), fencer İhsan Emre Vural (2008), Turkish rower for Galatasaray S.K. Sherif Farrag (2009), Egyptian-American Olympic fencer Nicholas la Cava (2009), Olympic rower Jeff Spear (2010), Olympic fencer Daria Schneider (2010), fencer Jeff Adams (2011), Houston Texans offensive tackle Nicole Ross (2011), Olympic fencer Isadora Cerullo (2013), Brazilian-American Olympic rugby player Katie Meili (2013), Olympic swimmer, Pan American Games and 2016 Summer Olympics gold medalist Josh Martin (2013), Kansas City Chiefs linebacker John Gregorek Jr. (2014), middle-distance runner David Najem (2014), American soccer player for New Mexico United and the Afghanistan national football team Nadia Eke (2015), Ghanaian triple jumper, African Championships gold medalist in 2016 Kristine Musademba (2015), figure skater Max Schnur (2015), tennis player playing on the ATP Challenger Tour Nzingha Prescod (2015), Olympic fencer Ramit Tandon (2015), professional squash player Jakub Buczek (2016), Canadian Olympic rower Sasha DiGiulian (2016), world champion climber Jacqueline Dubrovich (2016), Olympic fencer Maodo Lô (2016), German basketball player for Brose Bamberg Robb Paller (2016), American-Israeli Olympic baseball player Jeff Coby (2017), American basketball player for Xuventude Baloncesto Cameron Nizialek (2017), football player for Atlanta Falcons Akua Obeng-Akrofi (2018), Ghanaian sprinter Charlotte Buck (2018), Olympic rower Osama Khalifa (2018), #1 ranked college squash player in the U.S. for the 2016–17 season Camille Zimmerman (2018), American basketball player for Norrköping Dolphins Yasmeen Al-Dabbagh (2019), Saudi Arabian sprinter Jessica Antiles (2019), swimmer who won silver and bronze medals in the 2017 Maccabiah Games Dylan Castanheira (2019), soccer player, goalkeeper for Fort Lauderdale CF Sophie Whitehouse (2019), goalkeeper for Republic of Ireland women's national football team Mike Smith (2020), basketball player Anthony Jackie Tang (2020), Hong Kong tennis player John Tanguay (2020), rower who won a silver medal in the 2020 Summer Paralympics Dylan Geick* (2021), wrestler and internet personality Velavan Senthilkumar (2021), British Junior Open Squash champion and Asian Junior Squash champion Nastasya Generalova (2023), gymnast and model Olivia Giaccio (2024), Olympic freestyle skier Evita Griskenas (2024), rhythmic gymnast Camden Pulkinen (2024), figure skater Abbey Hsu (2024), basketball player
== Cell migration == The scratch assay is a great tool to study cell migration since this mechanism is involved in many different physiological aspects. Cell migration plays a huge role in re-epithelialization of the skin and so the study of cell migration can provide advancements in understanding non-healing wounds. Cell migration is also fundamental in developmental processes such as gastrulation and organogenesis. Cell migration is also involved in immune responses and cancer metastases.
Cannabis has an ancient history of ritual use and has been used by religions around the world. It has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. The earliest evidence of cannabis smoking has been found in the 2,500-year-old tombs of Jirzankal Cemetery in the Pamir Mountains in Western China, where cannabis residue were found in burners with charred pebbles possibly used during funeral rituals. Hemp seeds discovered by archaeologists at Pazyryk suggest early ceremonial practices like eating by the Scythians occurred during the 5th to 2nd century BC, confirming previous historical reports by Herodotus. It was used by Muslims in various Sufi orders as early as the Mamluk period, for example by the Qalandars. Smoking pipes uncovered in Ethiopia and carbon-dated to around c. AD 1320 were found to have traces of cannabis.
Calories consumed (food, drink) = Calories expended (basal metabolic rate, physical activity, thermogenic effect of food, acute illness) Outcome: Weight remains unchanged Calories consumed > Calories expended Also known as Positive Energy Balance Outcome: Weight increases Calories consumed < Calories expended Also known as Negative Energy Balance Outcome: Weight decreases The calories a person consumes come from food and drink intake. The calories a person expends comes from their basal metabolic rate and their daily physical activity. The human body is very good at maintaining a neutral energy balance, particularly with a diet composed of fruits, vegetables, and meats so that calories consumed do not substantially exceed calories expended in a given time period and vice versa. This energy balance is regulated by hormones like Leptin (suppresses), Ghrelin (stimulates), and Cholecystokinin (suppresses) which either suppress or stimulate appetite.
Sources: en.wikipedia.org
=== Municipal politics (2025–2026) === On September 17, 2025, Findlay became the advisory board chair of the Conservative Electors Association, a newly formed municipal party in British Columbia. Her role was to help with candidate recruitment and policy development. In February 2026, Findlay was involved in a launch event for the Conservative Electors Association, where they announced the slate of candidates for the 2026 Surrey municipal election.
Millions of people are affected by hyperhidrosis, but more than half never receive treatment due to embarrassment, lack of awareness, or lack of concern. While it most commonly affects the armpits, feet, and hands, it is possible for someone to experience this condition over their whole body. The face is another common area for hyperhidrosis to be an issue. Sweating uncontrollably is not always expected and may be embarrassing to people with the condition. It can cause both physiological and emotional problems in patients. It is generally inherited. It is not life-threatening, but it is threatening to a person's quality of life. Treatments for hyperhidrosis include antiperspirants, iontophoresis, and surgical removal of sweat glands. In severe cases, botulinum toxin injections or surgical cutting of nerves that stimulate the excessive sweating (endoscopic thoracic sympathectomy) may be an option.
other NSAIDs, corticosteroids: increased frequency of side effects, especially peptic ulcers and gastrointestinal bleeding diuretics, ACE inhibitors and other antihypertensive drugs: reduced effectiveness of these drugs with ACE inhibitors or ciclosporin, increased risk of kidney function disorders anticoagulants such as warfarin: increased risk of bleeding increased blood plasma concentrations of digoxin and methotrexate decreased plasma concentrations of lithium
== Clinical Significance == Deficiency of glutaryl-CoA dehydrogenase causes glutaric acidemia type 1, an autosomal recessive metabolic disorder.In this disorder, impaired metabolism of glutaryl-CoA is associated with elevated levels of organic acids, including glutaric acid and 3-hydroxyglutaric acid .
=== Pasteurization === Inactivation of viruses by means of pasteurization can be very effective if the proteins that you are trying to protect are more thermally resistant than the viral impurities with which they are in solution. Some of the more prominent advantages of these types of processes are that they require simple equipment and they are effective for both enveloped and non-enveloped viruses. Because pasteurization involves increasing the temperature of solution to a value that will sufficiently denature the virus, it does not matter whether the virus has an envelope or not because the envelope alone cannot protect the virus from such high temperatures. However, there are some proteins which have been found to act as thermal stabilizers for viruses. Of course, if the target protein is not heat-resistant, using this technique could denature that target protein as well as the viral impurity. Typical incubation lasts for 10 hours and is performed at 60 °C.
Sources: en.wikipedia.org
Compared to two other commonly used estradiol esters (which were also assessed in the study), estradiol cypionate had the longest duration, at approximately 11 days, whereas estradiol benzoate and estradiol valerate were found to last for 4 to 5 days and 7 to 8 days, respectively. This is because estradiol cypionate has a more extensive fatty acid chain and in relation to this is comparatively more lipophilic. For a given estradiol ester, the longer or more extensive the fatty acid chain is, the more lipophilic, longer-lasting, and more uniform/plateau-like the resultant levels of estradiol are as well as the lower the peak/maximal levels are (and hence less spike-like). Estradiol cypionate/medroxyprogesterone acetate (brand names Lunelle, Cyclofem) is a combined injectable contraceptive containing 5 mg estradiol cypionate and 25 mg medroxyprogesterone acetate in microcrystalline aqueous suspension for once-monthly intramuscular administration. With this formulations, estradiol levels peak 2 to 3 days post-injection with average maximal circulating levels of about 250 pg/mL. The elimination half-life of estradiol with these formulations is 8.4 to 10.1 days, and circulating estradiol levels return to a baseline of about 50 pg/mL approximately 14 to 24 days post-injection.
== Xenon-124 == Xenon-124 is an isotope of xenon that undergoes double electron capture to tellurium-124 with a very long half-life of 1.1×1022 years, approximately 12 orders of magnitude longer than the age of the universe. This decay was observed in the XENON1T detector in 2019, and is the slowest one ever directly observed. (Even slower decays of other nuclei have been measured, but by detecting decay products that have accumulated over billions of years rather than observing them directly.)
=== Treatment of type 2 diabetes === They are widely used as antidiabetic drugs in the management of diabetes mellitus type 2. They act by increasing secretion of insulin from the beta cells in the pancreas. Sulfonylureas are ineffective where there is absolute deficiency of insulin production such as in type 1 diabetes or post-pancreatectomy. Sulfonylureas can be used to treat some types of neonatal diabetes. Historically, people with hyperglycemia and low blood insulin levels were diagnosed with type 1 diabetes by default, but it has been found that patients who receive this diagnosis before 6 months of age are often candidates for receiving sulfonylureas rather than insulin throughout life. A 2011 Cochrane systematic review evaluated the effects on treatment of Latent Autoimmune Diabetes in Adults (LADA) and found that Sulfonylureas did not improve metabolic control of glucose at 3 and 12 months, even worsening HbA1c levels in some cases, when compared to insulin. The same review did not find improvement of fasting C-peptide following treatment with sulfonylurea. Still, it is important to highlight that the studies available to be included in this review presented considerable flaws in quality and design. While prior sulfonylureas were associated with worse outcomes, newer agents do not appear to increase the risk of death, heart attacks, or strokes.
A concentrate of proteolytic enzymes enriched in bromelain is approved in Europe for the debridement (removal of dead tissue) of severe burn wounds under the trade name NexoBrid. Bromelain has not been scientifically proven to be effective in treating any other diseases. Bromelain-containing dietary supplements are marketed with no confirmed efficacy, safety, recommended dosage, long term safety, or adverse interaction with other medications.
==== Shoulder disorders ==== A 2014 Cochrane review found insufficient evidence to determine whether electrotherapy was better than exercise at treating adhesive capsulitis. As of 2004, there is insufficient evidence to draw conclusions about any intervention for rotator cuff pathology, including electrotherapy; furthermore, methodological problems precluded drawing conclusions about the efficacy of any rehabilitation method for impingement syndrome.
Sources: en.wikipedia.org
Identity is confirmed by matching the retention time in reversed-phase chromatography against a reference standard and by measuring the molecular mass with mass spectrometry. Tandem mass spectrometry or amino acid analysis can verify the sequence of the seven residues. Because the peptide contains no aromatic amino acids, detection at 280 nm is not useful.
Lyophilized powder is normally stored desiccated at -20 °C, protected from light and moisture. Powder kept under these conditions is generally stable for long periods. Solutions are less stable and are usually prepared immediately before use.
A purity value from one chromatographic method does not capture every possible impurity. Related peptides with similar retention behavior, counterions, and residual solvents may not appear in the same analysis. Independent testing with an orthogonal method provides stronger assurance of identity and content.
The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter code. It combines the tetrapeptide tuftsin with a carboxyl-terminal Pro-Gly-Pro extension. This full sequence identifies the molecule more precisely than the research name.